• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD INC. (COVINGTON) -1018233 NICORE NITINOL GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD INC. (COVINGTON) -1018233 NICORE NITINOL GUIDEWIRE Back to Search Results
Catalog Number 150NSS35
Medical Device Problem Codes Material Protrusion/Extrusion (2979); Material Twisted/Bent (2981)
Health Effect - Clinical Code Exposure to Body Fluids (1745)
Date of Event 09/29/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that for the same patient undergoing the same procedure, after the guidewire was used to guide the ureteroscope into the ureter, the guidewire was withdrawn.The surface of the guidewire became wrinkled, rendering it unable to guide stent placement.Patient was exposed to bodily fluid.No medical intervention was reported.
 
Additional Manufacturer Narrative
The reported event was inconclusive because this investigation did not result in any additional findings and no sample was available for evaluation.Instructions for use were reviewed for this investigation.The labeling is found to be adequate.A review of the device history record did not show any problems or conditions that would have contributed to the reported issue.Corrections: d, f, h.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that for the same patient undergoing the same procedure, after the guidewire was used to guide the ureteroscope into the ureter, the guidewire was withdrawn.The surface of the guidewire became wrinkled, rendering it unable to guide stent placement.Patient was exposed to bodily fluid.No medical intervention was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NICORE NITINOL GUIDEWIRE
Common Device Name
NITINOL GUIDEWIRE
Manufacturer (Section D)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key23210070
Report Number1018233-2025-08808
Device Sequence Number9730011
Product Code EZB
UDI-Device Identifier00801741051524
UDI-Public(01)00801741051524(11)240730(17)290331(10)NGJS2259
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number150NSS35
Device Lot NumberNGJS2259
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/29/2025
Supplement Date Received by Manufacturer11/17/2025
Initial Report FDA Received Date10/03/2025
Supplement Report FDA Received Date11/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/30/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-